receptors, opioid, delta

Preferred Label : receptors, opioid, delta;

MeSH definition : A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.;

MeSH synonym : delta opioid receptor; delta opioid receptors; delta receptor; receptor, delta opioid; opioid receptors, delta; receptors, delta opioid; receptors, delta; receptor, delta; delta receptors; opioid receptor, delta;

Wikipedia automatic translation : Opioid receptor;

MeSH annotation : opioid receptors; DF: RECEPT DELTA;

Wikipedia link : https://en.wikipedia.org/wiki/Opioid receptor;

Is substance : O;

Détails

Origin ID

D017465;

UMLS CUI

C0140057;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Indexing information
- 1,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane [MeSH Supplementary Concept]
- 1-(4-tert-butyl-3'-hydroxybenzhydryl)-4-benzylpiperazine [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-4'-phenyl-6,7-2',3'-pyrrolomorphinan [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-6,7-didehydro-4,5-epoxy-5',6'-dihydro-3-methoxy-4'H-pyrrolo(3,2,1-ij)quinolino(2',1'-6,7)morphinan-14-ol [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-6,7-didehydro-4,5-epoxy-8'-fluoro-5',6'-dihydro-4'H-pyrrolo(3,2,1-ij)quinolino(2',1'-6,7)morphinan-3,14-diol [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-6,7-didehydro-4-hydroxy-3-methoxy-6,7-2',3'-indolomorphinan [MeSH Supplementary Concept]
- 17-cyclopropylmethyl-6,7-didehydro-quinolino(2',3'-6,7)morphinan-4-ol [MeSH Supplementary Concept]
- 2',6'-dimethyl-4'-(N-((4'-phenyl)phenethyl)carboxamido)phenylalanine-tetrahydroisoquinoline-3-carboxylic acid- phenylalanyl-phenylalanine [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl--1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-psi(CH2MH)-phenylalanyl-phenylalaninamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-alanine 1-adamantane amide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalaninamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carbonyl-glycine N-benzylamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (1H-benzimidazol-2-yl)(carboxymethyl)methylamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 1H-benzimidazol-2-ylmethylamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-beta-methylcyclohexylalanyl-phenylalanine [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-glutamamide [MeSH Supplementary Concept]
- 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinolinecarbonyl-phenylalanyl-(N(epsilon)-benzyloxycarbonyl)lysine [MeSH Supplementary Concept]
- 2,3-bis(benzoyloxy)tartaric acid [MeSH Supplementary Concept]
- 2-((diethylamino)carbonyl)-6-ethyl-8a-(3-hydroxyphenyl)-3-methyl-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrrolo(2,3-g)isoquinoline [MeSH Supplementary Concept]
- 2-amino-N-(6-benzyl-1,2,3,4-tetrahydroquinolin-4-yl)-3-(4-hydroxy-2,6-dimethylphenyl)propanamide [MeSH Supplementary Concept]
- 3,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone [MeSH Supplementary Concept]
- 3-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(4-fluorophenyl)-N-methylbenzamide [MeSH Supplementary Concept]
- 4'-(N-((4'-phenyl)phenethyl)carboxamido)phenylalanyl-tetrahydroisoquinoline-3-carboxylic acid- phenylalanyl-phenylalanine [MeSH Supplementary Concept]
- 4-((3-aminophenyl)(4-(4-fluorobenzyl)piperazin-1-yl)methyl)-N,N-diethylbenzamide [MeSH Supplementary Concept]
- 4-((4-((2-hydroxyethyl)methylcarbamoyl)phenyl)quinolin-8-yl-methylene)-1-thiazol-4-ylmethylpiperidinium [MeSH Supplementary Concept]
- 4-(4-((4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid [MeSH Supplementary Concept]
- 4-(alpha-(2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide [MeSH Supplementary Concept]
- 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide [MeSH Supplementary Concept]
- 4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide [MeSH Supplementary Concept]
- 4a,9-dihydroxy-7a-(hydroxymethyl)-3-methyl-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7(7aH)-one [MeSH Supplementary Concept]
- 5'-(4-chlorophenyl)-17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3-hydroxy-14-(3-phenylpropoxy)pyrido(2',3'-6,7)morphinan [MeSH Supplementary Concept]
- 5'-(4-chlorophenyl)-6,7-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylpyrido(2',3'-6,7)morphinan [MeSH Supplementary Concept]
- 5-(3-hydroxyphenyl)-4-methyl-2-(3-phenylpropyl)-2-azabicyclo(3.3.1)non-7-yl-(1-phenyl-1-cyclopentane)carboxamide [MeSH Supplementary Concept]
- 6,7-didehydro-17-isobutyl-quinolino(2',3'-6,7)morphinan-4-ol [MeSH Supplementary Concept]
- 6,7-didehydro-17-methyl-quinolino(2',3'-6,7)morphinan-4-ol [MeSH Supplementary Concept]
- 7-(2-methoxybenzylidene)naltrexone [MeSH Supplementary Concept]
- 7-(4-methylbenzylidene)naltrexone [MeSH Supplementary Concept]
- 7-(5',6'-benzo-2'-spiroindanyl)naltrexone [MeSH Supplementary Concept]
- 9-(8-azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide [MeSH Supplementary Concept]
- 9-hydroxy-5-(3-hydroxyphenyl)-2-phenylethyl-2-azabicyclo(3.3.1)nonane [MeSH Supplementary Concept]
- Dmt-NMe-Ala-Aba-Gly-NH2 [MeSH Supplementary Concept]
- KDAN 18 [MeSH Supplementary Concept]
- KNT 127 [MeSH Supplementary Concept]
- N(1)-(2',6'-dimethyltyrosyl-arginyl-phenylalanyl-lysyl)-N(2)-(tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-psi(CH2NH)-cyclohexylalanyl-phenylalanyl)ethylenediamine [MeSH Supplementary Concept]
- N,N(Me)2-dimethyl-tyrosine-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-OH [MeSH Supplementary Concept]
- N,N-diethyl-3-hydroxy-4-(spiro(chromene-2,4'-piperidine)-4-yl)benzamide [MeSH Supplementary Concept]
- N,N-diethyl-4-((8-phenethyl-8-azabicyclo(3.2.1)oct-3-ylidene)phenylmethyl)benzamide [MeSH Supplementary Concept]
- N,N-diethyl-4-(1-piperazinyl(8-quinolinyl)methyl)benzamide [MeSH Supplementary Concept]
- N,N-diethyl-4-(3-fluorophenylpiperidin-4-ylidenemethyl)benzamide [MeSH Supplementary Concept]
- N,N-diethyl-4-(5-hydroxyspiro(chromene-2,4'-piperidine)-4-yl)benzamide [MeSH Supplementary Concept]
- N,N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide [MeSH Supplementary Concept]
- N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl 1-adamantane amide [MeSH Supplementary Concept]
- N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide [MeSH Supplementary Concept]
- N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide [MeSH Supplementary Concept]
- N-(5-(3-hydroxyphenyl)-4-methyl-2-(3-phenylpropyl)-2-azabicyclo(3.3.1)non-7-yl)-2-methyl-2-phenylpropanamide [MeSH Supplementary Concept]
- RTI 5989-25 [MeSH Supplementary Concept]
- RV-Jim-C3 [MeSH Supplementary Concept]
- SB 206848 [MeSH Supplementary Concept]
- SB 213698 [MeSH Supplementary Concept]
- SB 219825 [MeSH Supplementary Concept]
- SB 222941 [MeSH Supplementary Concept]
- SB 235863A [MeSH Supplementary Concept]
- SDM 25N [MeSH Supplementary Concept]
- SNC 121 [MeSH Supplementary Concept]
- SoRI 9409 [MeSH Supplementary Concept]
- beta-casomorphins [MeSH Supplementary Concept]
- cyclo(prolyl-1-naphthylalanyl-tryptophyl-tyrosyl-threonyl-phenylalanyl) [MeSH Supplementary Concept]
- deltakephalin [MeSH Supplementary Concept]
- eluxadoline [MeSH Supplementary Concept]
- eribis peptide 94 [MeSH Supplementary Concept]
- methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate [MeSH Supplementary Concept]
- methyl-2',6'-dimethyltyrosinyltetrahydroisoquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- mitragynine [MeSH Supplementary Concept]
- rubiscolin 5 [MeSH Supplementary Concept]
- rubiscolin 6 [MeSH Supplementary Concept]
- tyrosyl-1,2,3,4-tetrahydro--3--isoquinolinecarbonyl-psi(CH2-NH)-cyclohexylalanyl-phenylalanine [MeSH Supplementary Concept]
- tyrosyl-1,2,3,4-tetrahydro--3-isoquinolinecarbonyl-phenylalanyl-phenylalaninamide [MeSH Supplementary Concept]
- tyrosyl-alanyl-glycyl-phenylalanyl-methionyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 [MeSH Supplementary Concept]
- tyrosyl-alanyl-glycyl-phenylalanyl-norleucyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 [MeSH Supplementary Concept]
- tyrosyl-alanyl-glycyl-tryptophyl-N-methylnorleucyl-aspartyl-phenylalaninamide [MeSH Supplementary Concept]
- tyrosyl-cyclo(allylglycyl-phenylalanyl-allylglycyl)amide [MeSH Supplementary Concept]
- tyrosyl-cyclo(penicillamyl-glycyl-4-iodophenylalanyl-cysteinyl)phenylalanine [MeSH Supplementary Concept]
- tyrosyl-cyclo(penicillamyl-glycyl-phenylalanyl-cysteinyl)phenylalanine [MeSH Supplementary Concept]
- tyrosyl-norleucyl-glycyl-tryptophyl-norleucyl-aspartyl-phenylalaninamide [MeSH Supplementary Concept]
- tyrosyl-phenylalanyl-glycyl-tryptophyl-N-methylnorleucyl-aspartyl-phenylalaninamide [MeSH Supplementary Concept]
Record concept(s)
- receptors, opioid, delta [MeSH concept]
Related MeSH Supplementary Concept(s)
- DOR-1 protein, mouse [MeSH Supplementary Concept]
- DOR2 protein, rat [MeSH Supplementary Concept]
- OPRD1 protein, human [MeSH Supplementary Concept]
- Oprd1 protein, rat [MeSH Supplementary Concept]
- oprd1a protein, zebrafish [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients